In 5 Years, Celestica Stock Has Gained More Than 4,000%, and Analysts Are Still Bullish

Celestica has been a phenomenal stock over the last five years, but future gains depend on the company meeting high earnings forecasts and sustaining demand.

Key Points
  • Celestica (TSX:CLS) has surged roughly 4,400% in five years — a $10,000 investment then would be worth about $449,540 — after becoming a major tech and electronics manufacturing partner.
  • Analysts forecast EPS growth of more than 60% annually from 2025–2028 and a PEG near 0.57, suggesting its valuation may still be reasonable relative to expected growth.
  • The consensus price target implies about 31% upside over 12 months, but future gains depend on Celestica meeting high earnings forecasts and sustaining demand.

Celestica (TSX: CLS) has delivered one of the most remarkable growth stories in the Canadian stock market over the past five years. The stock has gained approximately 4,400%, meaning a $10,000 investment made five years ago would now be worth roughly $449,540.

For investors looking for the next stage of that growth story, however, the more important question is whether Celestica still has room to run. Based on current analyst expectations and projected earnings growth, there are reasons investors may remain optimistic.

Illustration of data, cloud computing and microchips

Source: Getty Images

Celestica’s growth story is far from over

Celestica has evolved into a major technology and electronics manufacturing partner, benefiting from increasing demand for sophisticated infrastructure and technology products. That exposure has helped transform the company from a relatively overlooked Canadian stock into a high-growth name that has attracted considerable investor attention.

The earnings outlook is particularly compelling. Analyst consensus calls for earnings per share (EPS) growth of more than 60% annually from 2025 through 2028. If that pace of earnings expansion materializes, Celestica could continue growing into its valuation even if the stock’s price-to-earnings multiple does not expand further.

That distinction matters. After such an extraordinary rally, investors might reasonably assume Celestica has become prohibitively expensive. Yet its valuation does not necessarily look excessive when considered alongside its expected earnings growth.

The valuation still leaves room for upside

At approximately $519 per share at writing, Celestica trades at a forward price-to-earnings (P/E) ratio of roughly 33. On the surface, that is not a cheap multiple. But high-growth companies should not always be judged by their P/E ratios alone.

Celestica’s P/E-to-growth (PEG) ratio, which incorporates expected earnings growth into the valuation, is approximately 0.57. A PEG ratio below 1.0 may suggest that a company’s share price is relatively modest compared with its anticipated earnings growth, although such measures depend heavily on the accuracy of growth forecasts.

For Celestica, the combination of strong projected earnings growth and a PEG ratio below one provides an important counterpoint to its seemingly elevated P/E ratio.

What could drive the next leg higher?

The analyst outlook provides another reason for investors to keep Celestica on their watch list. The current consensus price target implies approximately 31% potential upside over the next 12 months.

Of course, analyst targets are estimates rather than guarantees. Celestica’s future performance will depend on its ability to deliver the earnings growth currently expected, maintain strong demand for its products and services, and justify its valuation.

Still, the numbers illustrate why the stock continues to attract attention. A company that has already gained more than 4,000% in five years would normally face enormous expectations. Celestica, however, enters its next chapter with analysts still forecasting substantial earnings growth and additional share-price upside.

The bottom line

Celestica’s extraordinary five-year return may make its past performance difficult to repeat, but its future growth prospects remain significant. 

With projected EPS growth exceeding 60% annually, a PEG ratio of about 0.57, and a consensus price target implying roughly 31% upside, the stock remains a notable Canadian growth story. 

Investors should nevertheless weigh these opportunities against the risks of paying a premium valuation for a company whose future growth must meet high expectations.

Fool contributor Kay Ng has positions in Celestica. The Motley Fool recommends Celestica. The Motley Fool has a disclosure policy.

More on Tech Stocks

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

I’d Keep Constellation Software Stock Despite its 3% Organic Growth: Here’s Why

Constellation Software's acquisition strategy has driven the company's success. The growth runway remains strong.

Read more »

data center server racks glow with light
Tech Stocks

AI Data Centres Need Power: This Canadian Stock Just Won a 1GW Contract

Enerflex has landed substantial data centre equipment work. The opportunity now depends on what reaches shareholders after delivery.

Read more »

man makes the timeout gesture with his hands
Tech Stocks

The Tax Rules Canadians Should Know Before Starting a Side Hustle

A side hustle can fund investments, but taxes, business expenses, and sales-tax obligations determine how much money is actually yours.

Read more »

atomic particle
Tech Stocks

This TSX Tech Stock Trades About $1,000 Below Its Consensus Target

Constellation's consensus target sits about $1,038 above its dated share price, while acquisition-driven growth determines whether the optimism is earned.

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

Celestica Raised Its 2026 Revenue Outlook to US$20.5 Billion: I Think the Stock Is a Buy Now

Here’s why Celestica’s growing role in AI infrastructure and its recent pullback make it one of the top Canadian stocks…

Read more »

quantum correlation
Tech Stocks

5N Plus Is Down 45% and Looks Cheap: The Price at Which it Becomes a Buy

With expanding production capacity, a robust order backlog, and favourable long-term industry trends, 5N Plus appears well-positioned for sustained growth,…

Read more »

telehealth stocks
Tech Stocks

1 Canadian Stock Down 42% to Buy and Hold Forever

This health tech stock is trading at a discount as it continues to grow and expand a business very much…

Read more »

space ship model takes off
Tech Stocks

Ottawa’s Defence Spending Boom: This Canadian Tech Stock is Already Cashing In

MDA has identifiable government and defence work, but its backlog and profit margins reveal more than the spending headlines.

Read more »